People: Merck & Co Inc (MRK)

MRK on New York Consolidated

60.89USD
29 May 2015
Change (% chg)

$1.19 (+1.99%)
Prev Close
$59.70
Open
$59.88
Day's High
$61.12
Day's Low
$59.47
Volume
19,862,397
Avg. Vol
11,318,804
52-wk High
$63.62
52-wk Low
$52.49

Search Stocks

Davis, Robert 

Mr. Robert M. Davis is Chief Financial Officer, Executive Vice President of Merck & Co., Inc., since April 23, 2014. Mr. Davis is responsible for the Company’s global financial organization, investor relations, corporate strategy and business development, global facilities, and the Company’s joint venture relationships. Prior to starting his employment with the Company, Mr. Davis served as Corporate Vice President and President, Medical Products of Baxter International, Inc. (“Baxter”), a healthcare company, a position he had held since October 2010. In that position, Mr. Davis was responsible for all aspects of commercial, R&D, quality, regulatory, manufacturing and supply chain functions. Prior to that position, Mr. Davis served as Corporate Vice President and President, Renal Division of Baxter in 2010 and had previously served as Baxter’s Corporate Vice President and Chief Financial Officer from 2006 to 2010.

Basic Compensation

Total Annual Compensation, USD 3,962,630
Restricted Stock Awards, USD 7,294,760
Long-Term Incentive Plans, USD --
All Other, USD 1,505,120
Fiscal Year Total, USD 12,762,500

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Kenneth Frazier

25,029,400

Robert Davis

12,762,500

Clark Golestani

--

Michael Holston

--

Bruce Kuhlik

6,172,880

Mirian Graddick-Weir

--
As Of  30 Dec 2014
Search Stocks